| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084931418 |
| P356 | DOI | 10.1186/S13052-017-0357-9 |
| P932 | PMC publication ID | 5395924 |
| P698 | PubMed publication ID | 28424095 |
| P50 | author | Francesco Gesualdo | Q42319490 |
| P2093 | author name string | Iria Neri | |
| Irene Berti | |||
| Valeria Boccaletti | |||
| Antonella Greco | |||
| Mario Cutrone | |||
| Andrea Diociaiuti | |||
| Maya El Hachem | |||
| Pietro Dalmonte | |||
| Teresa Oranges | |||
| Nadia Vercellino | |||
| Claudia Carnevale | |||
| Giulio Porcedda | |||
| P2860 | cites work | Conquering prematurity | Q26864826 |
| Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. | Q34034894 | ||
| Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment | Q34563146 | ||
| A randomized, controlled trial of oral propranolol in infantile hemangioma. | Q34668015 | ||
| Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies | Q35539585 | ||
| Treatment of infantile haemangiomas: recommendations of a European expert group | Q35645474 | ||
| Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature | Q37974840 | ||
| Infantile hemangiomas: an update on pathogenesis and therapy | Q38069789 | ||
| Propranolol and infantile hemangiomas four years later: a systematic review | Q38081161 | ||
| Haemangioma: clinical course, complications and management | Q38108844 | ||
| Diagnosis and management of infantile hemangiomas | Q38196581 | ||
| Vascular Anomalies Guidelines by the Italian Society for the study of Vascular Anomalies (SISAV). | Q41599767 | ||
| Propranolol for severe infantile hemangiomas: follow-up report | Q43286268 | ||
| Untreated hemangiomas: growth pattern and residual lesions | Q43478359 | ||
| A prospective study of infantile hemangiomas with a focus on incidence and risk factors | Q43521340 | ||
| Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas | Q43544104 | ||
| Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France | Q43965677 | ||
| Propranolol for severe hemangiomas of infancy. | Q46542573 | ||
| The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. | Q51361044 | ||
| Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases. | Q51666678 | ||
| Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. | Q51867476 | ||
| Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. | Q53595636 | ||
| Safety of Propranolol Therapy for Severe Infantile Hemangioma | Q56996359 | ||
| Infantile Hemangiomas With Unusually Prolonged Growth Phase | Q60607678 | ||
| Multicenter Prospective Study of Ulcerated Hemangiomas | Q60607683 | ||
| [Prevalence and characteristics of haemangiomas in young children] | Q81474949 | ||
| [Cardiorespiratory arrest following bronchiolitis in a child treated with propranolol for hemangioma] | Q85290815 | ||
| Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma | Q86164782 | ||
| [Infantile hemangiomas: the revolution of beta-blockers] | Q95605471 | ||
| P433 | issue | 1 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| P304 | page(s) | 40 | |
| P577 | publication date | 2017-04-19 | |
| P1433 | published in | Italian Journal of Paediatrics | Q15762169 |
| P1476 | title | Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience | |
| P478 | volume | 43 |
Search more.